Renminbi strengthens further despite gains by dollar

The renminbi on track for a fourth day of firming against the dollar on Wednesday after China’s central bank once again pushed the currency’s trading band (marginally) stronger. The onshore exchange rate (CNY) for the reniminbi was 0.28 per cent stronger at Rmb6.8855 in afternoon trade, bringing it 0.53 per cent firmer since it last […]

Continue Reading


Nomura rounds up markets’ biggest misses in 2016

Forecasting markets a year in advance is never easy, but with “year-ahead investment themes” season well underway, Nomura has provided a handy reminder of quite how difficult it is, with an overview of markets’ biggest hits and misses (OK, mostly misses) from the start of 2016. The biggest miss among analysts, according to Nomura’s Sam […]

Continue Reading


Spanish construction rebuilds after market collapse

Property developer Olivier Crambade founded Therus Invest in Madrid in 2004 to build offices and retail space. For five years business went quite well, and Therus developed and sold more than €300m of properties. Then Spain’s economy imploded, taking property with it, and Mr Crambade spent six years tending to Dhamma Energy, a solar energy […]

Continue Reading


Euro suffers worst month against the pound since financial crisis

Political risks are still all the rage in the currency markets. The euro has suffered its worst slump against the pound since 2009 in November, as investors hone in on a series of looming battles between eurosceptic populists and establishment parties at the ballot box. The single currency has shed 4.5 per cent against sterling […]

Continue Reading


RBS falls 2% after failing BoE stress test

Royal Bank of Scotland shares have slipped 2 per cent in early trading this morning, after the state-controlled lender emerged as the biggest loser in the Bank of England’s latest round of annual stress tests. The lender has now given regulators a plan to bulk up its capital levels by cutting costs and selling assets, […]

Continue Reading

Categorized | Equities

Cyberonics and Sorin merge in $3bn deal

Posted on February 26, 2015

Cyberonics' Vagus Nerve Stimulator pulse model 102©AP

Cyberonics of the US has agreed to merge with Italy’s Sorin to form a medical devices company with a combined equity value of nearly $3bn, which will be domiciled in the UK under a lower-tax regime.

Shares in Cyberonics jumped almost 25 per cent to $75.29 in Thursday morning trading in New York, with Sorin up 32.5 per cent at €2.91.

    The transaction, the second-largest US-Europe deal so far this year, underscores US companies’ continued appetite to strike deals that allow them to relocate to a lower tax jurisdiction despite a White House crackdown on so-called tax inversions.

    Executives at the two companies said that the decision to unite was driven by strategic interests rather than tax advantages. Yet the relocation to London will also help them cut their tax bill substantially as UK corporate tax is 21 per cent compared to 35 per cent in the US.

    “As one company we will be able to leverage our combined strengths, capture new opportunities and create new solutions to benefit patients and healthcare professionals alike,” said André-Michel Ballester, chief executive of the Milan-based company.

    The Cyberonics-Sorin combination, which will have a strategic presence in over 100 countries with approximately 4,500 employees, will apply for dual-listing on Nasdaq in New York and the London Stock Exchange.

    After the all-stock transaction is completed Sorin’s shareholders will own approximately 46 per cent of the combined company, while Cyberonics shareholders will control about 54 per cent, on a fully diluted basis.

    The combined company would have pro-forma revenues of approximately $1.3bn and is expected to be cash accretive to all shareholders from 2016, the company said in a statement.

    Houston, Texas-based Cyberonics, which develops medical equipment for the treatment of epilepsy and sleep apnoea, said the merger will help it bolster its presence in the growing business for the treatment of cardiovascular diseases.

    Mr Ballester will become the chief executive officer of the “NewCo” — a name for the new company has yet to be agreed — and Cyberonics’ Dan Moore will become the non-executive chairman.

    “While each company has a strong record of execution on its own, the geographic diversification, scale benefits and strong financial profile of the combined company will create tremendous new opportunities to drive growth and build significant shareholder value,” Mr Moore added.

    A rush of tax inversion deals from US groups seeking to lower their tax rates by buying foreign companies contributed to a frenzy of deal making in 2014, especially in healthcare, where M&A activity added up to $412.5bn out of a global total of $3.6tn.

    The wave of tax-driven deals came close to a standstill after the Obama administration made it harder to pursue fresh inversions but bankers focusing on tax structures said their clients were still looking for similar deals.

    “The logic has changed . . . now the deal is driven by strategic interests and then they think about whether they can also go for a tax inversion,” said a banker who has worked on scores of inversions.

    Rothschild is serving as financial adviser to Sorin Group, and Latham & Watkins is serving as its primary legal adviser. Piper Jaffray is serving as financial adviser to Cyberonics, and Sullivan & Cromwell is serving as its legal adviser, with Legance advising Cyberonics on Italian law matters.